Detalhe da pesquisa
1.
Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer.
iScience
; 27(5): 109801, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726365
2.
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
Med
; 5(4): 311-320.e3, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471508
3.
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
J Immunother Cancer
; 12(2)2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309721